Prakash Ambady, MD

Published Articles (1)

FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma

August 11, 2025

FDA grants accelerated approval to dordaviprone, the first systemic therapy for diffuse midline glioma with an H3 K27M mutation, offering new hope for patients after progression on prior treatment.